✦ LIBER ✦

S1030 Predictors of Response and Remission to Certolizumab Pegol in Patients With Crohn's Disease: Data From the WELCOME Study

✍ Scribed by William J. Sandborn; Maria T. Abreu; Geert R. D'Haens; Jean-Frederic Colombel; Severine Vermeire; Krassimir Mitchev; Etienne Ernault; Richard N. Fedorak; Martina Spehlmann; Douglas C. Wolf; Scott D. Lee; Paul J. Rutgeerts

Book ID: 119431599
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 142 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(10)60750-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1065 Predictors of Endoscopic Response

S1065 Predictors of Endoscopic Response and Remission in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: A Logistic Regression Analysis of the Music Data

✍ Jean-Frederic Colombel; Marc Lemann; Matthieu Allez; Krassimir Mitchev; Corinne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB

P005 ANALYSIS OF PREDICTORS OF RESPONSE

P005 ANALYSIS OF PREDICTORS OF RESPONSE MAINTENANCE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE CROHN'S DISEASE: DATA FROM PRECISE 2

✍ S. Hanauer; S. Schreiber; O. Thomsen; G. Lichtenstein; R. Bloomfield; W. Sandbor 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 66 KB

S1035 Certolizumab Pegol is Effective at

S1035 Certolizumab Pegol is Effective at Maintaining Response and Remission in Patients With Fistulising Crohn's Disease: 3-Year Results From the PRECiSE 3 Study

✍ Stefan Schreiber; Ian C. Lawrance; Ole O. Thomsen; Stephen B. Hanauer; Ralph Blo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

S1064 Certolizumab Pegol Effectiveness i

S1064 Certolizumab Pegol Effectiveness in Crohn's Disease Patients with Secondary Failure to Infliximab Is Independent of Infliximab Dosing: Results from the WELCOME Study

✍ Maria T. Abreu; Severine Vermeire; Paul J. Rutgeerts; Thomas A. Ullman; Douglas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Reinduction With Certolizumab Pegol in P

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study

✍ Sandborn, William J.; Schreiber, Stefan; Hanauer, Stephen B.; Colombel, Jean–Fré 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 781 KB

T1129 Predictors of Response in Patients

T1129 Predictors of Response in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: A Multiple Regression Analysis of PRECISE 2 Data

✍ Hanauer, Stephen B.; Schreiber, Stefan; Thomsen, Ole O.; Lichtenstein, Gary R.; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB